Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA260079
Max Phase: Preclinical
Molecular Formula: C28H24O7
Molecular Weight: 472.49
Molecule Type: Small molecule
Associated Items:
ID: ALA260079
Max Phase: Preclinical
Molecular Formula: C28H24O7
Molecular Weight: 472.49
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 4-(4-hydroxybenzylidene) curcumin
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(/C=C/C(=O)C(=Cc2ccc(O)cc2)C(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O
Standard InChI: InChI=1S/C28H24O7/c1-34-27-16-19(7-13-25(27)32)5-11-23(30)22(15-18-3-9-21(29)10-4-18)24(31)12-6-20-8-14-26(33)28(17-20)35-2/h3-17,29,32-33H,1-2H3/b11-5+,12-6+
Standard InChI Key: PNCPVSYJULULSS-YDWXAUTNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 472.49 | Molecular Weight (Monoisotopic): 472.1522 | AlogP: 4.77 | #Rotatable Bonds: 9 |
Polar Surface Area: 113.29 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.34 | CX Basic pKa: | CX LogP: 5.88 | CX LogD: 5.83 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.23 | Np Likeness Score: 0.34 |
1. Mishra S, Karmodiya K, Surolia N, Surolia A.. (2008) Synthesis and exploration of novel curcumin analogues as anti-malarial agents., 16 (6): [PMID:18194869] [10.1016/j.bmc.2007.12.054] |
2. Rišiaňová L, Fischer-Fodor E, Valentová J, Tatomir C, Corina Decea N, Virag P, Pechová I, Devínsky F, Miklášová N.. (2017) Synthesis, structural characterization and biological activity of novel Knoevenagel condensates on DLD-1 human colon carcinoma., 27 (11): [PMID:28438541] [10.1016/j.bmcl.2017.04.031] |
Source(1):